Introduction to Immune Reactions in the Peripheral Nervous System

Peripheral Neuropathy

Volumn 1, Issue , 2005, Pages 559-572

  Hartung, Hans Peter ^a   Kieseier, Bernd C ^a   Gold, Ralf ^b   Stoll, Guido ^b   Toyka, Klaus V ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745260759     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50028-4     Document Type: Chapter

References (109)

1. Abbas A.K., Sharpe A.H. T-cell stimulation: an abundance of B7s. Nat. Med. 1999, 5:1345.
2. Akkaraju S., Ho W.Y., Leong D., et al. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 1997, 7:255.
3. Albert L.J., Inman R.D. Molecular mimicry and autoimmunity. N. Engl. J. Med. 1999, 341:2068.
4. Archelos J.J., Previtali S.C., Hartung H.-P. The role of integrins in immune-mediated diseases of the nervous system. Trends Neurosci. 1999, 22:30.
5. Armati P.J., Pollard J.D. Immunology of the Schwann cell. Baillieres Clin. Neurol. 1996, 5:47.
6. Armati P.J., Pollard J.D., Gatenby P. Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve 1990, 13:106.
7. Arnason B.G.W., Soliven B. Acute inflammatory demyelinating polyradiculoneuropathy. Peripheral Neuropathy 1993, 3:1437. W. B. Saunders, Philadelphia. P.J. Dyck, P.K. Thomas, J.W. Griffin (Eds.).
8. Arvidson B. Cellular uptake of exogenous horseradish peroxidase in mouse peripheral nerve. Acta Neuropathol. (Berl.) 1977, 37:35.
9. Bach J.F. Autoimmune diseases as the loss of active "self-control." Ann. N. Y. Acad. Sci. 2003, 998:161.
10. Barker C.F., Billingham R.E. Immunologically privileged sites. Adv. Immunol. 1977, 25:1.
11. Bolin L.M., Verity A.N., Silver J.E., et al. InterleGBRin-6 production by Schwann cells and induction in sciatic nerve injury. J. Neurochem. 1995, 64:850.
12. Bonetti B., Valdo P., Ossi G., et al. T-cell cytotoxicity of human Schwann cells: TNFalpha promotes fasL-mediated apoptosis and IFN gamma perforin-mediated lysis. Glia 2003, 43:141.
13. Brigl M., Brenner M.B. CD1: Antigen presentation and T cell function. Annu. Rev. Immunol. 2004, 22:817.
14. Brosnan C.F., Tansey F.A. Delayed onset of experimental allergic neuritis in rats treated with reserpine. J. Neuropathol. Exp. Neurol. 1984, 43:84.
15. Buchwald B., Weishaupt A., Toyka K.V., Dudel J. Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals. Eur. J. Neurosci. 1998, 10:281.
16. Chambers C.A., Allison J.P. Costimulatory regulation of T cell function. Curr. Opin. Cell Biol. 1999, 11:203.
17. Chen W., Wahl S.M. TGF-beta: receptors, signaling pathways and autoimmunity. Curr. Dir. Autoimmun. 2002, 5:62.
18. Chen Y., Kuchroo V.K., Inobe J.-L., et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J. Exp. Med. 1994, 265:1237.
19. Christen U., von Herrath M.G. Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol. Immunol. 2004, 40:1113.
20. Constable A.L., Armati P.J., Toyka K.V., Hartung H.P. Production of prostanoids by Lewis rat Schwann cells in vitro. Brain Res. 1994, 635:75.
21. D'Ambrosio D., Sinigaglia F., Adorini L. Special attractions for suppressor T cells. Trends Immunol. 2003, 24:122.
22. Dashiell S.M., Vanguri P., Koski C.L. Dibutyryl cyclic AMP and inflammatory cytokines mediate C3 expression in Schwann cells. Glia 1997, 20:308.
23. Dilley A., Gregson N.A., Hadden R.D., Smith K.J. Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barre syndrome. J. Neuroimmunol. 2003, 139:133.
24. Dutronc Y., Porcelli S.A. The CD1 family and T cell recognition of lipid antigens. Tissue Antigens 2002, 60:337.
25. Ferber I., Schörich G., Schenkel J., et al. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 1994, 263:674.
26. Frossi B., De Carli M., Pucillo C. The mast cell: an antenna of the microenvironment that directs the immune response. J. LeGBRoc. Biol. 2004, 75:579.
27. Fujinami R.S., Oldstone M.B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985, 230:1043.
28. Gold R., Archelos J.J., Hartung H.-P. Mechanisms of immune regulation in the peripheral nervous system. Brain Pathol. 1999, 9:343.
29. Gold R., Oelschlager M., Pepinsky R.B., et al. Increased lipocortin-1 (annexin-1) expression in the sciatic nerve of Lewis rats with experimental autoimmune neuritis. Acta Neuropathol. (Berl.) 1999, 98:583.
30. Gold R., Toyka K.V., Hartung H.P. Synergistic effect of IFN-gamma and TNF-alpha on expression of immune molecules and antigen presentation by Schwann cells. Cell. Immunol. 1995, 165:65.
31. Gold R., Zielasek J., Kiefer R., et al. Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro. Cell. Immunol. 1996, 168:69.
32. Goodnow C.C., Crosbie J., Adelstein S., et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988, 334:676.
33. Gorelik L., Flavell R.A. Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2002, 2:46.
34. Griffin J.W., George R., Ho T. Macrophage system in peripheral nerves: a review. J. Neuropathol. Exp. Neurol. 1993, 52:553.
35. Harris L.J., Larson S.B., McPherson A. Comparison of intact antibody structures and the implications for effector function. Adv. Immunol. 1999, 72:191.
36. Hartung H.-P. Pathogenesis of inflammatory demyelination: implications for therapy. Curr. Opin. Neurol. 1995, 8:191.
37. Hartung H.-P., Pollard J.D., Harvey G.K., Toyka K.V. Invited review-immunopathogenesis and treatment of the Guillain-Barré syndrome. Parts I and II. Muscle Nerve 1995, 18:137.
38. Hartung H.-P., van der Meché F.G.A., Pollard J.D. Guillain-Barré syndrome, CIDP and other chronic immunemediated neuropathies. Curr. Opin. Neurol. 1998, 11:497.
39. Hemmer B., Vergelli M., Pinilla C., et al. Probing degeneracy in T-cell recognition using peptide combinatorial libraries. Immunol. Today 1998, 19:163.
40. Heyman B. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol. 2000, 18:709.
41. Hila S., Soane L., Koski C.L. Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phospho-rylation of BAD. Glia 2001, 36:58.
42. Ho T.W., McKhann G.M., Griffin J.W. Human autoimmune neuropathies. Annu. Rev. Neurosci. 1998, 21:187.
43. Hughes R.A.C., Hadden R.D.M., Gregson N.A., Smith K.J. Pathogenesis of Guillain-Barré syndrome. J. Neuroimmunol. 1999, 100:74.
44. Huppa J.B., Davis M.M. T-cell-antigen recognition and the immunological synapse. Nat. Rev. Immunol. 2003, 3:973.
45. Iezzi G., Scheidegger D., Lanzavecchia A. Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J. Exp. Med. 2001, 193:987.
46. Infante-Duarte C., Horton H.F., Byrne M.C., Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 2000, 165:6107.
47. Jacobs B.C., O'Hanlon G.M., Bullens R.W., et al. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain 2003, 126:2220.
48. Jahnke U., Fischer E.H., Alvord E.C.J. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 1985, 229:282.
49. Jonuleit H., Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 2003, 171:6323.
50. Kamradt T., Mitchison N.A. Tolerance and autoimmunity. N. Engl. J. Med. 2001, 334:655.
51. Khalili-Shirazi A., Gregson N.A., Londei M., et al. The distribution of CD1 molecules in inflammatory neuropathy. J. Neurol. Sci. 1998, 158:154.
52. Kiefer R., Dangond F., Mueller M., et al. Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies. J. Neurol. Neurosurg. Psychiatry 2000, 69:362.
53. Kiefer R., Funa K., Schweitzer T., et al. Transforming growth factor-beta 1 in experimental autoimmune neuritis: cellular localization and time course. Am. J. Pathol. 1996, 148:211.
54. Kiefer R., Kieseier B.C., Stoll G., Hartung H.P. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog. Neurobiol. 2001, 64:109.
55. Kieseier B.C., Clements J.M., Pischel H.B., et al. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barre syndrome. Ann. Neurol. 1998, 43:427.
56. Kieseier B.C., Tani M., Mahad D., et al. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain 2002, 125:823.
57. King C., Ilic A., Koelsch K., Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004, 117:265.
58. Koski C.L., Estep A.E., Sawant-Mane S., et al. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins. J. Neurochem. 1996, 66:303.
59. Krampfl K., Mohammadi B., Buchwald B., et al. IgG from patients with Guillain-Barre syndrome interacts with nicotinic acetylcholine receptor channels. Muscle Nerve 2003, 27:435.
60. Matsumoto I., Staub A., Benoist C., Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999, 286:1732.
61. Maurer M., Toyka K.V., Gold R. Cellular immunity in inflammatory autoimmune neuropathies. Rev. Neurol. (Paris) 2002, 158:S7.
62. Mitchison N.A. T-cell-B-cell cooperation. Nat. Rev. Immunol. 2004, 4:308.
63. Mueller M., Wacker K., Ringelstein E.B., et al. Rapid response of identified resident endoneurial macrophages to nerve injury. Am. J. Pathol. 2001, 159:2187.
64. Muller W.A. LeGBRocyte-endothelial-cell interactions in leGBRocyte transmigration and the inflammatory response. Trends Immunol. 2003, 24:327.
65. Nauta A.J., Daha M.R., vanKooten C., Roos A. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol. 2003, 24:148.
66. Nemazee D. Receptor selection in B and T lymphocytes. Annu. Rev. Immunol. 2000, 18:19.
67. Nemazee D.A., Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989, 337:562.
68. Nikolich-Zugich J., Slifka M.K., Messaoudi I. The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 2004, 4:123.
69. Olson J.K., Ludovic Croxford J., Miller S.D. Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry. Mol. Immunol. 2004, 40:1103.
70. O'Shea J.J., Ma A., Lipsky P. Cytokines and autoimmunity. Nat. Rev. Immunol. 2002, 2:37.
71. Perron H., Garson J.A., Bedin F., et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:7583.
72. Pestka S., Krause C.D., Sarkar D., et al. InterleGBRin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004, 22:929.
73. Pollard J.D., Baverstock J., McLeod J.G. Class II antigen expression and inflammatory cells in the Guillain-Barre syndrome. Ann. Neurol. 1987, 21:337.
74. + T cells. J. Exp. Med. 1996, 183:2669.
75. Putzu G.A., Figarella-Branger D., Bouvier-Labit C., et al. Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barre syndrome. J. Neurol. Sci. 2000, 174:16.
76. Rathmell J.C., Thompson C.B. The central effect of cell death in the immune system. Annu. Rev. Immunol. 1999, 17:781.
77. Rathmell J.C., Townsend S.E., Xu J.C., et al. Expansion or elimination of B cell in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996, 87:319.
78. Ravetch J.V., Bolland S. IgG Fc receptors. Annu. Rev. Immunol. 2001, 19:275.
79. Redegeld F.A., Van Der Heijden M.W., Kool M., et al. Functional role for Ig free light chains in immediate and delayed hypersensitivity responses. Inflamm. Res. 2004, 53(Suppl. 1):S6.
80. Sakaguchi S. Policing the regulators. Nat. Immunol. 2001, 2:283.
81. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004, 22:531.
82. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 2001, 19:225.
83. Sawant-Mane S., Piddlesden S.J., Morgan B.P., et al. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells. J. Neuroimmunol. 1996, 69:63.
84. Schmidt B., Toyka K.V., Kiefer R., et al. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 1996, 19:474.
85. Sebzda E., Mariathasan S., Ohteki T., et al. Selection of the T cell repertoire. Annu. Rev. Immunol. 1999, 17:829.
86. Seeldrayers P.A., Yasui D., Weiner H.L., Johnson D. Treatment of experimental allergic neuritis with nedocromil sodium. J. Neuroimmunol. 1989, 25:221.
87. Sharpe A.H., Freeman G.J. The B7-CD28 super-family. Nat. Rev. Immunol. 2002, 2:116.
88. Shevach E.M. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 2000, 18:423.
89. Skundric D.S., Lisak R.P., Rouhi M., et al. Schwann cell-specific regulation of IL-1 and IL-1Ra during EAN: possible relevance for immune regulation at paranodal regions. J. Neuroimmunol. 2001, 116:74.
90. Song W.C. Membrane complement regulatory proteins in autoimmune and inflammatory tissue injury. Curr. Dir. Autoimmun. 2004, 7:181.
91. SusGBRi K., Nishimoto Y., Yamada M., et al. Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann. Neurol. 2003, 54:383.
92. SusGBRi K., Odaka M., Mori M., et al. Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry. Neurology 2004, 62:949.
93. Tough D.F., Sun S., Sprent J. T cell stimulation in vivo by lipopolysaccharide (LPS). J. Exp. Med. 1997, 185:2089.
94. Tsokos G.C., Fleming S.D. Autoimmunity, complement activation, tissue injury and reciprocal effects. Curr. Dir. Autoimmun. 2004, 7:149.
95. Van Rhijn I., Van den Berg L.H., Bosboom W.M., et al. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy. Brain 2000, 123(Pt. 10):2020.
96. Vedeler C.A., Conti G., Fujioka T., et al. The expression of CD59 in experimental allergic neuritis. J. Neurol. Sci. 1999, 165:154.
97. Vedeler C., Ulvestad E., Bjorge L., et al. The expression of CD59 in normal human nervous tissue. Immunology 1994, 82:542.
98. + Treg: divide and rule?. Immunology 2004, 111:129.
99. Walker L.S., Abbas A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2002, 2:11.
100. Weishaupt A., Bruck W., Hartung T., et al. Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-alpha. Neurosci. Lett. 2001, 306:77.
101. Wekerle H., Schwab M., Linington C., Meyermann R. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur. J. Immunol. 1986, 16:1551.
102. Wim Ang C., Jacobs B.C., Laman J.D. The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol. 2004, 25:61.
103. Wohlleben G., Ibrahim S.M., Schmidt J., et al. Regulation of Fas and FasL expression on rat Schwann cells. Glia 2000, 30:373.
104. Wolf K., Muller R., Borgmann S., et al. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 2003, 102:3262.
105. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T-cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995, 80:695.
106. YGBRi N., Yamada M., Koga M., et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 gangliosides. Ann. Neurol. 2001, 49:712.
107. Zettl U.K., Gold R., Toyka K.V., Hartung H.P. In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat. Acta Neuropathol. (Berl.) 1996, 91:360.
108. Zhu J., Mix E., Link H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barre syndrome. J. Neuroimmunol. 1998, 84:40.
109. Zuniga-Pflucker J.C. T-cell development made simple. Nat. Rev. Immunol. 2004, 4:67.